Tenet Reports Third Quarter 2022 Results; Announces $1 Billion Share Repurchase Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Tenet Healthcare (THC) Tops Q3 EPS by 18c; $1B Buyback Announced
October 20, 2022 4:08 PM EDTTenet Healthcare (NYSE: THC) reported Q3 EPS of $1.44, $0.18 better than the analyst estimate of $1.26. Revenue for the quarter came in at $4.8 billion versus the consensus estimate of $4.8 billion.
Board of Directors has authorized a $1 billion share repurchase program.
GUIDANCE:
FY 2022... More
